Evommune Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$21.36

+0.71 (+3.44%)

As of Jun 21, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +254.9% upside

Low Target $52.19

Average Target $75.80

High Target $91.23

Current Price $21.36

Current
$21.36

Target
$75.80

$52.19 $75.80 avg $91.23

Scenario Analysis

Bear Case

$52.19

144.3%

Low target

Base Case

$75.80

+254.9%

Avg target

Bull Case

$91.23

+327.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$33.20

-35.7% from high

52-Week Low

$13.89

+53.8% from low

Target vs 52W High

$75.80

+128.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%